Unknown

Dataset Information

0

Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study.


ABSTRACT:

Purpose

Maintaining high adherence rates (session attendance and compliance) in exercise programs during breast cancer treatment can be challenging. We aimed to identify adherence rates and predictors to an exercise program during adjuvant breast cancer treatment.

Methods

Ninety-two patients with localized breast cancer undergoing chemotherapy were randomly assigned to an 18-week supervised moderate-to-high intensity aerobic and resistance exercise program, including two 1-hour sessions/week. Additionally, participants were asked to be physically active for at least 30 minutes/day on at least three other days. We report median percentages for attendance, compliance with the prescribed duration and intensity of aerobic and muscle strength exercises, and the exercise advice given. Predictors included in univariate and multivariable linear regression models were demographical, tumor- and treatment-related factors, constructs of the theory of planned behavior, psychological and physical factors.

Results

Patients attended 83% (interquartile range: 69-91%) of the supervised sessions. Compliance with the duration of aerobic exercise, high-intensity aerobic exercise (cycling at the ventilatory threshold), muscle strength exercises and the exercise advice were 88%(64-97%), 50%(22-82%), 84%(65-94%) and 61%(33%-79%), respectively. Education, radiotherapy, BMI and physical fatigue were important predictors of adherence to supervised exercise. Beliefs about planned behaviors were important predictors, especially for compliance with the exercise advice.

Conclusions

Attendance to and compliance with an 18-week aerobic and strength exercise program were high. The lowest compliance was found for high-intensity supervised aerobic exercise. The identified predictors should be considered when designing or adapting exercise programs for patients with localized breast cancer to increase adherence.

Trial registration

Current Controlled Trials ISRCTN43801571 Dutch Trial Register NTR2138.

SUBMITTER: Witlox L 

PROVIDER: S-EPMC6505930 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7161977 | biostudies-literature
| S-EPMC10405203 | biostudies-literature
| S-EPMC3683950 | biostudies-literature
| S-EPMC8386357 | biostudies-literature
| S-EPMC3436790 | biostudies-literature
| S-EPMC9040347 | biostudies-literature
| S-EPMC5903657 | biostudies-literature
| S-EPMC10040268 | biostudies-literature
| S-EPMC4255415 | biostudies-literature
| S-EPMC8910269 | biostudies-literature